Blood and marrow transplantation and cellular therapies are important treatment options for several kinds of cancer, including leukemia, lymphoma and myeloma. These therapies also offer the potential of cure for marrow failure, immune deficiency states, some genetic disorders, benign blood disorders and autoimmune diseases.
Patients receive advanced care for these and other conditions through our Leukemia, Lymphoma and Myeloma Program as well as our Benign Hematology Program. Such diseases were considered untreatable even a generation ago and are now successfully treated with bone marrow and stem cell transplant, as well as cellular therapies.
The abbreviation "BMT" can stand for blood and marrow transplant or the more specific bone marrow transplant — both involve harvesting and transplanting blood stem cells to cure a variety of diseases and conditions, cancerous and noncancerous alike. Conditions we treat include:
Blood Cancers
- Leukemia
- Acute and chronic leukemia
- Acute myeloid leukemia
- Acute lymphocytic leukemia
- Chronic myeloid leukemia
- Chronic lymphocytic leukemia
- Mast cell leukemia
- Lymphoma
- Hodgkin and Non-Hodgkin lymphoma
- Multiple myeloma
Benign Blood Disorders — These serious diseases are not classified as cancer, but some may progress to cancer.
- Autoimmune disorders
- Amyloidosis
- Aplastic anemia
- Bone marrow failure syndrome
- Germ cell tumors
- Hemophagocytic lymphohistiocytosis or HLH
- Hemophilia
- Immunodeficiencies
- Mast cell leukemia
- Myelodysplastic syndromes, including
- Paroxysmal nocturnal hemoglobinuria or PNH
- Sickle cell disease